Tutorials › Biostatistics › Logistic Regression Part 2: A Worked Clinical Example

Clinical Regression Methods

Logistic Regression Part 2: A Worked Clinical Example

A practical, step-by-step clinical example of multivariable logistic regression, showing how to model a binary clinical endpoint, estimate adjusted treatment effects, interpret odds ratios and confidence intervals, calculate predicted probabilities, and implement the analysis in R and SAS.

Advanced 20 min read

What You'll Learn

  • How logistic regression is used for a binary clinical endpoint
  • How to specify a multivariable clinical logistic model
  • How to interpret adjusted odds ratios and confidence intervals
  • How treatment effects can change after covariate adjustment
  • How to calculate and interpret predicted probabilities
  • How to implement and report the analysis in R and SAS

Introduction

Logistic regression is one of the most important regression methods used in clinical research when the primary outcome is binary.

Examples include:

  • Responder vs. non-responder
  • Remission vs. no remission
  • Event vs. no event
  • Adverse event vs. no adverse event
  • Disease progression vs. no progression
  • Successful treatment vs. unsuccessful treatment

In Part 1, the central idea is that logistic regression models the probability of a binary outcome through the logit transformation. Part 2 takes the next step and works through a complete clinical example.

Key idea: The coefficient from a logistic regression model is on the log-odds scale. Exponentiating the coefficient converts it to an odds ratio, which is usually the most clinically interpretable way to report the effect.

The Clinical Question

Suppose a randomized clinical trial compares a new treatment with control. The primary binary endpoint is whether a patient achieves a predefined clinical response at Week 12.

The investigators want to answer two questions:

  1. Does treatment increase the probability of response?
  2. Does the treatment effect remain after adjusting for important baseline covariates?

The second question motivates the multivariable logistic regression model.

Defining the Outcome

Let:

\[ Y_i = \begin{cases} 1, & \text{if patient } i \text{ is a responder at Week 12}\\ 0, & \text{otherwise} \end{cases} \]

The probability of response for patient \(i\) is:

\[ p_i=P(Y_i=1) \]

Because \(p_i\) must lie between 0 and 1, directly modeling the probability with ordinary linear regression can produce impossible predicted values.

Logistic regression instead models the log odds:

\[ \operatorname{logit}(p_i) = \log\left(\frac{p_i}{1-p_i}\right) \]

The Multivariable Clinical Model

Suppose the model includes:

  • \(X_1\) = treatment indicator
  • \(X_2\) = baseline age
  • \(X_3\) = baseline disease severity score

Let treatment be coded:

Variable Value Meaning
treatment = 0 0 Control
treatment = 1 1 Experimental treatment

The logistic regression model is:

\[ \operatorname{logit}(p_i) = \beta_0 + \beta_1\operatorname{Treatment}_i + \beta_2\operatorname{Age}_i + \beta_3\operatorname{Severity}_i \]

Equivalently:

\[ \log\left(\frac{p_i}{1-p_i}\right) = \beta_0 + \beta_1\operatorname{Treatment}_i + \beta_2\operatorname{Age}_i + \beta_3\operatorname{Severity}_i \]
Interpretation: The model does not assume that the probability of response changes linearly with the predictors. Instead, it assumes that the log odds of response are linear in the predictors.

A Synthetic Clinical Dataset

For this worked example, consider a synthetic Phase III dataset containing 300 patients, with 150 patients assigned to each treatment group.

The binary endpoint is response at Week 12.

Variable Description
Response 1 = responder; 0 = non-responder
Treatment 1 = experimental; 0 = control
Age Baseline age in years
Severity Baseline disease severity score

The observed response rates are:

Treatment Group Patients Responders Observed Response Rate
Control 150 30 20.0%
Experimental 150 86 57.3%

The crude treatment comparison already suggests a substantial treatment effect. However, the clinical analysis may also need to account for baseline covariates.

Crude Odds Ratio Before Adjustment

Before fitting the multivariable model, calculate the unadjusted odds ratio.

For the control group:

\[ \text{Odds}_{C} = \frac{30}{150-30} = \frac{30}{120} = 0.25 \]

For the experimental treatment:

\[ \text{Odds}_{T} = \frac{86}{150-86} = \frac{86}{64} = 1.34375 \]

Therefore, the crude odds ratio is:

\[ OR_{\text{crude}} = \frac{1.34375}{0.25} = 5.375 \]

Thus, the unadjusted odds of response are approximately 5.38 times higher in the experimental group than in the control group.

Important: The crude odds ratio is not necessarily the same as the adjusted treatment odds ratio. Adjustment accounts for the other variables included in the regression model.

Fitting the Logistic Regression Model

Suppose the fitted model produces the following coefficient estimates:

Parameter Estimate Standard Error P-value
Intercept 2.929 0.994 0.003
Treatment 1.804 0.280 <0.001
Age -0.038 0.014 0.008
Severity -0.772 0.198 <0.001

The fitted equation is therefore approximately:

\[ \operatorname{logit}(p) = 2.929 + 1.804(\operatorname{Treatment}) - 0.038(\operatorname{Age}) - 0.772(\operatorname{Severity}) \]

Interpreting the Treatment Coefficient

The treatment coefficient is:

\[ \hat{\beta}_1=1.804 \]

This is a change in log odds, not a change in probability.

To obtain the odds ratio, exponentiate the coefficient:

\[ OR = e^{1.804} \approx 6.07 \]

Therefore, after adjusting for age and baseline severity, the estimated odds of response are approximately 6.07 times higher for the experimental treatment than for control.

Clinical interpretation: Holding age and baseline disease severity constant, patients receiving the experimental treatment have estimated odds of response approximately 6.1 times those of patients receiving control.

Why "6 Times More Likely" Is Incorrect

A common reporting error is to say:

"Patients were six times more likely to respond."

That wording is generally incorrect because the logistic regression coefficient produces an odds ratio, not a risk ratio or probability ratio.

The correct statement is:

Preferred wording: "The adjusted odds of response were approximately 6.1 times higher in the experimental treatment group than in the control group."

The distinction matters especially when the outcome is common. Odds and probabilities can differ substantially when event rates are not small.

Converting the Treatment Effect to a Confidence Interval

Suppose the 95% confidence interval for the treatment coefficient on the log-odds scale is approximately:

\[ 1.804 \pm 1.96(0.280) \]

This gives approximately:

\[ 1.255 \le \beta_1 \le 2.353 \]

Exponentiating both limits gives the confidence interval for the odds ratio:

\[ e^{1.255} \le OR \le e^{2.353} \]
\[ 3.51 \le OR \le 10.52 \]

Thus the adjusted treatment effect can be reported as approximately:

\[ \boxed{OR=6.07,\quad 95\%\,CI:\ 3.51\text{ to }10.52} \]

Because the confidence interval excludes 1, the treatment effect is statistically significant at the conventional two-sided 5% level.

Interpreting the Age Coefficient

The age coefficient is:

\[ \hat{\beta}_{Age}=-0.038 \]

The corresponding odds ratio is:

\[ OR_{Age} = e^{-0.038} \approx 0.963 \]

Therefore, for a one-year increase in age, the estimated odds of response are multiplied by approximately 0.963, holding treatment and severity constant.

Equivalently, the odds decrease by approximately:

\[ (1-0.963)\times100\% \approx3.7\% \]

per additional year of age.

Scaling matters: A one-year odds ratio may be difficult to interpret clinically. If appropriate, the effect can instead be reported per 5-year or 10-year increase.

Interpreting Age Per 10 Years

Because the age coefficient represents one year, the odds ratio for a 10-year increase is:

\[ OR_{10\text{-year}} = e^{10(-0.038)} \approx 0.684 \]

Thus, holding treatment and severity constant, a 10-year increase in age is associated with approximately 31.6% lower odds of response.

\[ (1-0.684)\times100\% \approx31.6\% \]

Interpreting Baseline Severity

The severity coefficient is:

\[ \hat{\beta}_{Severity}=-0.772 \]

Its odds ratio is:

\[ OR_{Severity} = e^{-0.772} \approx 0.462 \]

Thus, for a one-unit increase in baseline severity, the odds of response are multiplied by approximately 0.462, holding treatment and age constant.

This corresponds to approximately a:

\[ (1-0.462)\times100\% = 53.8\% \]

decrease in the odds of response per one-unit increase in severity.

The Full Odds-Ratio Table

A typical clinical regression table might therefore look like this:

Predictor Adjusted OR 95% CI P-value
Experimental vs. control 6.07 3.51–10.52 <0.001
Age, per year 0.963 approximately 0.936–0.990 0.008
Severity, per unit 0.462 approximately 0.313–0.683 <0.001

For a clinical report, the treatment effect would usually be the primary parameter of interest, while the baseline covariates provide adjustment and additional clinical context.

From Odds Ratios to Predicted Probabilities

Odds ratios are useful, but clinicians often find probabilities easier to interpret.

The inverse-logit transformation converts a linear predictor back to a probability:

\[ p = \frac{e^\eta}{1+e^\eta} \]

where:

\[ \eta = \beta_0+\beta_1X_1+\beta_2X_2+\beta_3X_3 \]

Predicted Probability for a Control Patient

Consider a hypothetical control patient with:

  • Age = 55 years
  • Severity = 3.0
  • Treatment = 0

The linear predictor is:

\[ \eta_C = 2.929 + 1.804(0) - 0.038(55) - 0.772(3) \]

Therefore:

\[ \eta_C = 2.929-2.090-2.316 = -1.477 \]

The predicted probability is:

\[ p_C = \frac{e^{-1.477}}{1+e^{-1.477}} \approx0.186 \]

So the predicted probability of response for this representative control patient is approximately 18.6%.

Predicted Probability for an Experimental Patient

Now change only treatment from control to experimental.

The linear predictor becomes:

\[ \eta_T = 2.929 + 1.804(1) - 0.038(55) - 0.772(3) \]

Thus:

\[ \eta_T = -1.477+1.804 = 0.327 \]

The predicted probability is:

\[ p_T = \frac{e^{0.327}}{1+e^{0.327}} \approx0.581 \]

The representative experimental patient therefore has an estimated probability of response of approximately 58.1%.

Representative Patient Treatment Predicted Probability
Age 55, severity 3.0 Control 18.6%
Age 55, severity 3.0 Experimental 58.1%
Why this is useful: Predicted probabilities translate a regression model into quantities that can be easier to communicate clinically. They also demonstrate why an odds ratio cannot simply be interpreted as a probability ratio.

Adjusted vs. Unadjusted Treatment Effects

The crude odds ratio was approximately:

\[ OR_{\text{crude}}\approx5.38 \]

The adjusted odds ratio from the multivariable model is approximately:

\[ OR_{\text{adjusted}}\approx6.07 \]

These estimates are not identical.

The crude estimate compares treatment groups without accounting for age or severity. The adjusted estimate compares treatment groups after accounting for the covariates in the specified model.

Analysis Treatment OR Interpretation
Unadjusted 5.38 Crude treatment association
Adjusted 6.07 Treatment association conditional on age and severity
Do not automatically assume adjustment is better. Covariates should be selected using clinical and statistical reasoning and, for a confirmatory clinical trial, should generally be prespecified. Adding variables simply because they happen to be statistically significant can lead to unstable or difficult-to-interpret models.

R Implementation

A logistic regression can be fit in R using glm() with the binomial family.

model <- glm(
  response ~ treatment + age + severity,
  data = clinical_data,
  family = binomial(link = "logit")
)

summary(model)

The coefficient estimates are on the log-odds scale.

To obtain odds ratios:

exp(coef(model))

To obtain 95% Wald confidence intervals for the odds ratios:

results <- cbind(
  OR = exp(coef(model)),
  exp(confint.default(model))
)

results
Practical note: For clinical reporting, specify whether confidence intervals are Wald, profile-likelihood, or another prespecified method. Different methods can produce slightly different intervals, particularly with smaller samples or less stable models.

Obtaining Predicted Probabilities in R

Predicted probabilities can be generated using type = "response".

new_patient_control <- data.frame(
  treatment = 0,
  age = 55,
  severity = 3.0
)

new_patient_treatment <- data.frame(
  treatment = 1,
  age = 55,
  severity = 3.0
)

predict(
  model,
  newdata = new_patient_control,
  type = "response"
)

predict(
  model,
  newdata = new_patient_treatment,
  type = "response"
)

This produces probabilities on the original 0-to-1 scale rather than on the log-odds scale.

SAS Implementation

In SAS, the corresponding analysis can be performed with PROC LOGISTIC.

proc logistic data=clinical_data;
    class treatment(ref='0') / param=ref;

    model response(event='1') =
        treatment
        age
        severity;

    oddsratio treatment;
    oddsratio age;
    oddsratio severity;
run;

The event='1' option makes the modeled event explicit: the probability of being a responder.

SAS reporting point: Always verify which outcome level SAS is modeling. A reversal of the modeled event can reverse the interpretation of the odds ratios.

Why the EVENT Definition Matters

Suppose response is coded:

  • 1 = responder
  • 0 = non-responder

Then the model should estimate:

\[ P(Y=1) = P(\text{response}) \]

If the event is accidentally defined as the non-response category, the model will estimate:

\[ P(Y=0) = P(\text{non-response}) \]

The resulting odds ratios will be interpreted in the opposite direction.

Best practice: In every clinical logistic regression analysis, explicitly document the endpoint coding and modeled event. Never assume that the software's default event definition matches the intended clinical endpoint.

Checking the Model

Fitting the model is not the end of the analysis.

Important questions include:

  • Are the covariates clinically appropriate?
  • Are continuous covariates modeled appropriately?
  • Are there sparse cells or separation?
  • Are influential observations present?
  • Is the model excessively complex for the available number of events?
  • Does the model discriminate between responders and non-responders?
  • Is calibration adequate?

Linearity on the Logit Scale

A particularly important assumption concerns continuous predictors.

For example, the model above assumes that:

\[ \operatorname{logit}(p) = \beta_0+\beta_1Age+\cdots \]

This means the relationship between age and the log odds is linear.

It does not mean that the probability itself changes linearly with age.

Clinical implication: If the relationship between age and outcome is strongly nonlinear, forcing a simple linear age term can produce misleading estimates. Splines, clinically meaningful categories, transformations, or other prespecified approaches may be considered when justified.

Interactions

A basic logistic model assumes that the treatment effect is the same across the levels of the included covariates unless interaction terms are included.

For example, a treatment-by-age interaction could be written as:

\[ \operatorname{logit}(p) = \beta_0 + \beta_1Treatment + \beta_2Age + \beta_3Treatment\times Age \]

In that model, the treatment effect depends on age.

The treatment odds ratio at a particular age is no longer simply \(e^{\beta_1}\).

Instead, it depends on the interaction term.

Do not add interactions automatically. Interactions should generally have a scientific rationale, such as a prespecified hypothesis that treatment efficacy differs according to a baseline characteristic.

Odds Ratio vs. Risk Ratio

One of the most important distinctions in clinical interpretation is the difference between odds and risk.

Suppose two groups have response probabilities:

\[ p_T=0.60 \qquad p_C=0.30 \]

The risk ratio is:

\[ RR = \frac{0.60}{0.30} = 2.0 \]

But the odds ratio is:

\[ OR = \frac{0.60/0.40}{0.30/0.70} = 3.5 \]

Thus an odds ratio of 3.5 does not mean the probability is 3.5 times as high.

Measure Definition
Risk \(p\)
Odds \(p/(1-p)\)
Risk ratio \(p_T/p_C\)
Odds ratio \(\text{Odds}_T/\text{Odds}_C\)

Model Discrimination

A logistic model can also be evaluated for its ability to distinguish patients with and without the event.

A common measure is the area under the receiver operating characteristic curve, or AUC.

\[ AUC=P(\text{model score for a random case} > \text{model score for a random non-case}) \]

An AUC near 0.5 indicates little discrimination, while larger values indicate better discrimination.

However, a strong AUC does not prove that the model is well calibrated.

Model Calibration

Calibration asks whether predicted probabilities agree with observed outcome frequencies.

For example, among patients predicted to have approximately 70% probability of response, we would ideally observe a response rate close to 70%.

Discrimination vs. calibration: Discrimination asks whether the model ranks patients correctly. Calibration asks whether the predicted probabilities are numerically accurate.

Separation and Sparse Data

Logistic regression can become unstable when a predictor or combination of predictors almost perfectly separates responders from non-responders.

For example, suppose every patient with a particular rare baseline characteristic responds and every patient without it fails.

Maximum likelihood estimates may become extremely large or fail to converge.

This problem is called separation.

Potential approaches include:

  • Reviewing the clinical data for sparse cells
  • Reducing unnecessary model complexity
  • Combining clinically appropriate sparse categories
  • Using penalized or exact methods when justified
  • Prespecifying appropriate handling in the statistical analysis plan

Clinical Interpretation of the Worked Example

The main result from our example is:

\[ \boxed{ OR_{\text{adjusted}} = 6.07 \quad 95\%\,CI: 3.51\text{--}10.52 } \]

The interpretation is:

Clinical conclusion: After adjustment for baseline age and disease severity, the experimental treatment was associated with substantially higher odds of Week 12 response than control. The estimated adjusted odds ratio was approximately 6.1, with a 95% confidence interval from approximately 3.5 to 10.5.

The model also suggests that increasing age and greater baseline severity are associated with lower odds of response, although the scientific importance of these associations should be considered separately from the primary treatment comparison.

How to Report the Result

A concise clinical-trial report might state:

Example reporting language: "Multivariable logistic regression was used to evaluate Week 12 response, with treatment group as the primary predictor and baseline age and disease severity included as covariates. The adjusted odds of response were higher with experimental treatment than with control (OR 6.07; 95% CI 3.51–10.52; P < 0.001)."

This wording identifies:

  • The endpoint
  • The statistical method
  • The adjustment variables
  • The treatment comparison
  • The adjusted odds ratio
  • The confidence interval
  • The P-value

What Not to Report

Avoid statements such as:

  • "Treatment increased response by 607%."
  • "Patients were 6.07 times more likely to respond."
  • "The probability of response was 6.07 times higher."
  • "The treatment caused a six-fold increase in response probability."

These statements confuse odds ratios with probability or risk ratios.

Preferred terminology: Use "odds of response" when interpreting an odds ratio. Use "probability" or "risk" only when discussing the corresponding probability or risk measure.

A Practical Analysis Workflow

1
Define the binary endpoint and explicitly identify the event being modeled.
2
Define treatment coding and reference categories.
3
Prespecify clinically relevant baseline covariates.
4
Fit the logistic regression model using the logit link.
5
Review coefficient estimates, standard errors, confidence intervals, and P-values.
6
Exponentiate coefficients to obtain odds ratios.
7
Evaluate model assumptions, separation, influential observations, discrimination, and calibration.
8
Calculate clinically meaningful predicted probabilities when useful.
9
Report the adjusted treatment effect with its confidence interval and exact or appropriately formatted P-value.
10
Interpret odds ratios as odds ratios rather than probability ratios.

Common Mistakes

  1. Calling an odds ratio a risk ratio. An odds ratio and a risk ratio are different measures.
  2. Interpreting \(e^\beta\) as a probability change. Exponentiating a logistic coefficient produces an odds ratio.
  3. Ignoring the reference category. Every categorical treatment or covariate effect is interpreted relative to its specified reference level.
  4. Failing to specify the modeled event. Reversing the event definition reverses the direction of interpretation.
  5. Adding many covariates without justification. An unnecessarily complex model can become unstable, especially with limited numbers of events.
  6. Assuming continuous predictors are automatically linear. Logistic regression assumes linearity on the logit scale for ordinary continuous predictor terms.
  7. Reporting only the P-value. The estimated effect and confidence interval are essential for understanding magnitude and precision.
  8. Confusing adjusted and unadjusted estimates. The crude treatment comparison and the multivariable treatment effect answer different questions.
  9. Assuming statistical significance implies clinical importance. A small P-value does not by itself establish that an effect is clinically meaningful.
  10. Ignoring model diagnostics. Convergence, separation, influential observations, discrimination, and calibration should be considered.

When Logistic Regression Is Especially Useful

Logistic regression is particularly useful when:

  • The primary endpoint is binary.
  • Adjustment for baseline prognostic factors is desired.
  • The treatment effect needs to be expressed as an odds ratio.
  • Multiple predictors are clinically relevant.
  • Predicted probabilities are useful for interpretation or prediction.
  • Effect modification or interactions are scientifically important.

When Logistic Regression May Not Be the Best Choice

Logistic regression is not automatically the best model for every clinical endpoint.

Endpoint Potentially Appropriate Method
Continuous outcome Linear regression / ANCOVA
Time-to-event outcome Cox proportional hazards or another survival model
Repeated binary outcomes GEE or mixed-effects logistic regression
Ordinal outcome Ordinal logistic regression or related model
Count outcome Poisson or negative binomial regression

The model should be selected based on the structure of the endpoint and the scientific question, not simply because logistic regression is familiar.

One More Important Distinction: Association vs. Prediction

The worked example is primarily an inferential clinical model. The principal question is whether treatment is associated with response after adjustment for prespecified covariates.

A predictive model has a different goal: accurately predicting outcomes for future patients.

Predictive modeling may require additional considerations such as:

  • Internal validation
  • Bootstrap validation
  • Cross-validation
  • Calibration assessment
  • Optimism correction
  • External validation
  • Prediction intervals or uncertainty assessment
Bottom line: A statistically significant treatment coefficient does not automatically mean that the model is a good prediction model. Inference and prediction are related but distinct goals.

The Complete Worked Example in One View

Component Result
Endpoint Week 12 binary response
Total sample size 300
Control patients 150
Experimental patients 150
Control response rate 20.0%
Experimental response rate 57.3%
Crude treatment OR 5.38
Adjusted treatment coefficient 1.804
Adjusted treatment OR 6.07
95% CI for treatment OR 3.51–10.52
Treatment P-value <0.001
Age OR per year 0.963
Severity OR per unit 0.462
Predicted response, representative control patient 18.6%
Predicted response, representative treatment patient 58.1%

The Most Important Concept

The most important lesson from a clinical logistic regression analysis is that the model connects three different scales:

1
Probability scale: the clinically observed probability of response.
2
Odds scale: \(p/(1-p)\), which compares the probability of an event with the probability of no event.
3
Log-odds scale: the scale on which the regression predictors enter linearly.

The model is fit on the log-odds scale, coefficients are exponentiated to produce odds ratios, and the inverse-logit transformation converts the fitted model back into predicted probabilities.

\[ \boxed{ \operatorname{logit}(p) \longrightarrow \beta \longrightarrow e^\beta=OR \longrightarrow p=\frac{e^\eta}{1+e^\eta} } \]
Bottom line: In a clinical trial with a binary endpoint, multivariable logistic regression provides a principled way to estimate an adjusted treatment effect while accounting for prespecified baseline covariates. The coefficients are on the log-odds scale, exponentiating them produces adjusted odds ratios, and the inverse-logit transformation provides predicted probabilities. The key to correct interpretation is to distinguish odds from probability, identify the modeled event and reference categories, and report effect estimates together with confidence intervals rather than relying on P-values alone.

References

Hosmer, D.W., Lemeshow, S. & Sturdivant, R.X. (2013). Applied Logistic Regression. 3rd ed. Wiley.

Agresti, A. (2018). An Introduction to Categorical Data Analysis. 3rd ed. Wiley.

Harrell, F.E. (2015). Regression Modeling Strategies. 2nd ed. Springer.

Vittinghoff, E., Glidden, D.V., Shiboski, S.C. & McCulloch, C.E. (2012). Regression Methods in Biostatistics. 2nd ed. Springer.

SAS Institute Inc. PROC LOGISTIC Documentation.

R Core Team. R: A Language and Environment for Statistical Computing.

Clinical Trials

See logistic regression in real clinical trials

See the method applied to published trial results, with the estimates, confidence intervals and interpretation explained.

SOCRATES
Independent statistical analysis of the SOCRATES phase 3 trial of ticagrelor versus acetylsalicylic acid after acute ischaemic stroke or transient ischaemic attack,…
Phase 3 · n = 13,307
THALES
Complete statistical analysis of the phase 3 THALES trial of ticagrelor versus placebo in acute ischaemic stroke and transient ischaemic attack, including…
Phase 3 · n = 11,016
Partners PrEP
An independent statistical analysis of the Partners PrEP phase 3 trial, examining TDF and FTC/TDF for prevention of HIV-1 acquisition in HIV-1…
Phase 3 · n = 4,758
ABCSG-18
Independent statistical analysis of ABCSG-18, a randomized phase 3 trial of denosumab in patients with breast cancer receiving aromatase inhibitor therapy, including…
Phase 3 · n = 3,420
EPIC-HR
Independent statistical analysis of the EPIC-HR randomized phase 2/3 trial of PF-07321332/ritonavir versus placebo in nonhospitalized high-risk adults with COVID-19, including endpoint…
Phase 2/3 · n = 2,091
SURPASS-4
Independent statistical analysis of SURPASS-4, a randomized phase 3 trial of once-weekly tirzepatide versus once-daily insulin glargine in participants with type 2…
Phase 3 · n = 2,002
See all 47 trials using logistic regression →